“…Gene perturbation in mammalian cells can be performed either at the endogenous locus of a specific target via effector proteins that activate transcription, such as CRISPR-Cas ( Chavez et al., 2016 ) or exogenously through cDNA expression via inducible or constitutive promoters ( Arnoldo et al., 2014 ). Both CRISPR and cDNA technologies have been leveraged in recent mammalian screens to effectively target genes of interest in an individual or combinatorial manner ( Chavez et al., 2015 , 2016 ; Konermann et al., 2014 ; Qi et al., 2013 ; Horlbeck et al., 2016 ; Bikard et al., 2013 ; Gilbert et al., 2013 ; Zalatan et al., 2015 ; Tak et al., 2017 ; Zhang et al., 2017 ; Liu et al., 2019 ; Yeo et al., 2018 ; Shimojima et al., 2020 ; Parekh et al., 2018 ).…”